Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG) investors of a class action representing investors that bought securities between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"). Neogen investors have until September 16, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. P ...

Core Viewpoint - A class action has been filed against Neogen Corporation for allegedly misleading investors regarding its integration with 3M Company, which has negatively impacted its financial health [2][3]. Group 1: Allegations and Financial Impact - The complaint states that Neogen issued false statements about the smooth progress of its integration with 3M, failing to disclose significant integration issues [2]. - On January 10, 2025, Neogen reported a GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a 5% decline in stock price to $12.36 per share [3]. - On April 9, 2025, Neogen announced a 3.4% drop in quarterly revenue to $221 million, attributed to integration issues, and cut its fiscal year 2025 revenue and EBITDA outlook, resulting in a 28% drop in stock price [4]. Group 2: Stock Performance and Market Capitalization - On June 4, 2025, Neogen projected an EBITDA margin in the high teens, down from 22% in the previous quarter, causing an additional 17% decline in stock price to $4.96 per share [5]. - From a high of $23.84 per share on August 15, 2023, Neogen's stock price fell by $18.88, or 79%, erasing over $4 billion in market capitalization [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to allegations of misleading investors regarding its integration with 3M Company, which has negatively impacted its financial health [2][3]. Financial Performance - On January 10, 2025, Neogen reported a GAAP net income that was significantly negative, primarily due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition [3]. - Neogen cut its fiscal year 2025 revenue and EBITDA guidance following the negative financial disclosures [3]. - On April 9, 2025, Neogen announced a quarterly revenue decline of 3.4% to $221 million, attributing part of this to integration issues, and again revised its FY25 revenue and EBITDA outlook downward [4]. - The company projected capital expenditures of $100 million due to lowered adjusted EBITDA and a pull-forward of integration-related capital expenditures into FY25 [4]. - On June 4, 2025, Neogen expected its EBITDA margin to be in the high teens, a significant drop from the previous quarter's margin of 22% [5]. Stock Performance - Following the January 10, 2025 announcement, Neogen's stock price fell by 5% to close at $12.36 per share [3]. - After the April 9, 2025 announcement, the stock price plummeted by 28% [4]. - By June 4, 2025, the stock price had further declined by 17%, closing at $4.96 per share, marking a total drop of $18.88 per share or 79% from its August 15, 2023 high of $23.84 per share, erasing over $4 billion in market capitalization [5].

Core Viewpoint - Neogen Corporation is facing a class action securities lawsuit due to alleged securities fraud that misled investors regarding the integration with the Food Safety Division of 3M Company [1][2] Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by misleading statements made between January 5, 2023, and June 3, 2025 [1] - Defendants allegedly issued materially false statements about the integration's progress and downplayed inefficiencies that arose during the process [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until September 16, 2025, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a strong track record, having secured hundreds of millions for shareholders and ranked among the top securities litigation firms in the U.S. for seven consecutive years [4]

Core Viewpoint - Neogen Corporation (NASDAQ: NEOG) is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its integration with the Food Safety Division of 3M Company, which misled investors about the progress of the integration [3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from January 5, 2023, to June 3, 2025 [3]. - The complaint alleges that Neogen's management downplayed inefficiencies arising from the integration and misled investors about their commitment to resolving these issues [3]. - Shareholders are encouraged to register for the class action by September 16, 2025, to potentially be appointed as lead plaintiffs [4]. Group 2: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged misleading statements and failure to disclose material facts regarding the integration of 3M's Food Safety Division, leading to significant financial losses for investors [4][7]. Group 1: Company Overview - Neogen Corporation develops, manufactures, and markets products focused on food and animal safety, and completed a strategic merger with 3M's Food Safety Division in September 2022 [3]. Group 2: Allegations and Financial Impact - The lawsuit claims that Neogen misrepresented the progress of the integration, which was actually facing operational and financial difficulties [5]. - Neogen reported a GAAP net loss of $461 million due to a non-cash goodwill impairment related to the 3M acquisition, along with downward revisions to revenue and EBITDA guidance for 2025 [5]. - In Q3 2025, Neogen experienced a net loss of $11 million, a decline in revenue by 3.4% to $221 million, and increased capital expenditures projected at $100 million due to integration spending [5]. - Following these disclosures, Neogen's stock fell approximately 28% and then dropped more than 17% after announcing a significant decline in EBITDA margin expectations [6].

SAN DIEGO, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Neogen Corporation (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"), have until Tuesday, September 16, 2025 to seek appointment as lead plaintiff of the Neogen class action lawsuit. Captioned Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation, No. 25-cv-00802 (W.D. Mich.), the Neogen class ac ...

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration with 3M and the financial health of the company during the class period from January 5, 2023, to June 3, 2025 [1][3]. Company Overview - Neogen Corporation, along with its subsidiaries, specializes in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Allegations of the Lawsuit - The lawsuit claims that Neogen's executives made false or misleading statements about the progress of the integration with 3M, leading investors to believe it was more successful than it was [3]. - It is alleged that when Neogen disclosed "inefficiencies" from the integration, the executives downplayed these issues and assured investors of their commitment to resolving them [3]. Financial Performance and Impact - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, leading to a more than 5% drop in stock price [4]. - The third quarter results on April 9, 2025, showed a loss of $11 million, a revenue decline of 3.4% to $221 million, and a 28% drop in stock price following the announcement [5]. - On June 4, 2025, Neogen projected an EBITDA margin drop to the high teens from 22%, resulting in a more than 17% decline in stock price [6]. Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Neogen common stock during the class period to seek appointment as lead plaintiff, representing the interests of the class [7]. Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8][9].

SAN DIEGO, July 30, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (NASDAQ: NEOG) securities between January 6, 2023 and June 3, 2025. Neogen is a food safety company that manufactures and markets products and services dedicated to food and animal safety. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. According to the complaint, during ...

Core Viewpoint - Neogen Corporation is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company and its executives misled investors regarding the integration of its business with 3M's Food Safety Division and the financial implications of this merger [1][3][4]. Company Overview - Neogen Corporation specializes in the development, manufacture, and marketing of products and services focused on food and animal safety [2]. Class Action Details - The class action lawsuit is titled "Operating Engineers Construction Industry and Miscellaneous Pension Fund v. Neogen Corporation" and allows investors who purchased Neogen common stock between January 5, 2023, and June 3, 2025, to seek appointment as lead plaintiff by September 16, 2025 [1][7]. - The lawsuit alleges that Neogen's executives made false statements about the progress of the integration with 3M and downplayed inefficiencies that arose during this process [3][4]. Financial Performance - On January 10, 2025, Neogen reported a significant GAAP net income loss due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition, alongside a reduction in fiscal year 2025 revenue and EBITDA guidance [4]. - In the third quarter of 2025, Neogen reported a loss of $11 million, a significant increase from a $2 million loss the previous year, with revenue declining by 3.4% to $221 million due to integration issues [5]. - On June 4, 2025, Neogen projected an EBITDA margin drop to the high teens from 22%, attributing this to elevated inventory write-offs, which led to a further decline in stock price by over 17% [6].